Each month we provide an overview of University of Missouri School of Medicine faculty-authored articles in medicine and related fields as well as a featured article with the highest journal impact factor.
This month’s featured article, “Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial” was co-authored by Dr. Richard Barohn, Executive Vice Chancellor for Health Affairs and Dean. The article was published in Lancet Neurology (impact factor of 46.5 in 2023).
See the list of publications in medicine and related fields we retrieved for this month: https://library.muhealth.org/facpubmonthlyresult/?Month=September&Year=2024